Drug Discovery News: Silence in healthy cells makes FOXR2 a potential cancer target
Drug Discovery News recently highlighted research coauthored by the University of Cincinnati's Timothy Phoenix, PhD, focused on a gene called FOXR2.
FOXR2 is usually not expressed in most healthy cells, but the research team found it is abnormally expressed in more than 70% of 10,000 different adult and pediatric cancer types the team analyzed
The research team also found that FOXR2 bound to the DNA sequences that normally associate with E26 transformation-specific (ETS) transcription factors (ETS TFs), which control the expression of genes with a variety of cellular functions.
“FOXR2 and ETS TFs can interact on DNA and actually turn genes on and off, which can cause cancer,” said Phoenix, assistant professor in UC’s James L. Winkle College of Pharmacy Division of Pharmaceutical Sciences and a University of Cincinnati Cancer Center researcher.
Moving forward, the team aims to learn more about exactly how FOXR2 functions and the proteins it interacts with, with long-term goals of developing targets for new treatments.
Read the Drug Discovery News story.
Featured photo at top of Phoenix in his lab. Photo/Colleen Kelley/UC Marketing + Brand
Related Stories
More young adults are having strokes than three decades ago
September 23, 2026
A University of Cincinnati-led study published in the journal Neurology found that strokes among adults ages 20 to 54 nearly doubled over almost three decades, even as short-term survival after stroke improved.
UC part of $18 million initiative to expand behavioral health workforce in Ohio
September 23, 2026
The University of Cincinnati is participating in a new $18 million statewide scholarship program, as Cleveland.com recently reported, to address critical shortages of mental health and substance use treatment providers across Ohio.
Unlike many parents, children are fearless around AI
September 23, 2026
Researchers at the University of Cincinnati found that children ages 5-10 are enthusiastic about playing with new AI toys but also tend to believe what the AI tells them. Their embrace of AI contrasts with concerns expressed by some of their parents.